Noble Financial Keeps Evoke Pharma (EVOK) at 'Hold' Following Q2 Numbers; Still Awaiting Development Plans

August 16, 2016 8:43 AM

Noble Financial affirms Evoke Pharma (Nasdaq: EVOK) with a Hold rating following Q2 results issued Monday night.Analyst Nathan Cali noted ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found